| Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of - PR Newswire (press release) |
|
|
PR Newswire (press release)Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal ... read more |